Lin TH et al. |
NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. |
2015 |
Tissue Eng Part A |
pmid:25518013
|
Hasegawa T et al. |
Human periodontal ligament cells derived from deciduous teeth induce osteoclastogenesis in vitro. |
2002 |
Tissue Cell |
pmid:11989970
|
Carda C et al. |
Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint. |
2005 |
Tissue Cell |
pmid:15899507
|
Mikosch P et al. |
High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy. |
2008 |
Thyroid |
pmid:18302515
|
Martini G et al. |
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels. |
2008 |
Thyroid |
pmid:18399769
|
Vinholt PJ et al. |
An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma. |
2013 |
Thromb. Res. |
pmid:23531238
|
Guldiken B et al. |
Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct. |
2007 |
Thromb. Res. |
pmid:17258300
|
Hyseni A et al. |
Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients. |
2013 |
Thromb. Res. |
pmid:23273402
|
Vik A et al. |
Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study. |
2012 |
Thromb. Res. |
pmid:22909822
|
O'Sullivan EP et al. |
Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status. |
2010 |
Thromb. Res. |
pmid:20932553
|
Al-Fakhri N et al. |
Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossification. |
2005 |
Thromb. Haemost. |
pmid:16411417
|
Vik A et al. |
Heparin induces mobilization of osteoprotegerin into the circulation. |
2007 |
Thromb. Haemost. |
pmid:17598007
|
Vik A et al. |
Serum osteoprotegerin in young survivors of myocardial infarction. |
2006 |
Thromb. Haemost. |
pmid:16676081
|
Hofbauer LC et al. |
Interleukin-4 differentially regulates osteoprotegerin expression and induces calcification in vascular smooth muscle cells. |
2006 |
Thromb. Haemost. |
pmid:16601843
|
Kees M et al. |
Elevated plasma osteoprotegerin levels are associated with venous thrombosis and bleeding in patients with polycythemia vera. |
2005 |
Thromb. Haemost. |
pmid:15630493
|
Celińska-Löwenhoff M et al. |
Effects of hypolipemic drugs on the osteoprotegerin - sRANKL system in patients with coronary artery disease. |
2007 |
Thromb. Haemost. |
pmid:17479201
|
Brandenburg V et al. |
Calcification inhibitors in vascular calciphylaxis associated with normal renal function. |
2012 |
Thromb. Haemost. |
pmid:23092963
|
Hess U |
[The plasma cell myeloma--molecular pathogenesis and target therapies]. |
2006 |
Ther Umsch |
pmid:16689452
|
Chasseraud M et al. |
Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification. |
2011 |
Ther Apher Dial |
pmid:21426505
|
Kazama JJ et al. |
Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism. |
2006 |
Ther Apher Dial |
pmid:16817791
|